Although this allows us to reveal how CCL2-CCR2 and CGRP pathways differentially contribute to the establishment and the resolution of chronic migraine and MOH, our conclusions need to be verified in additional preclinical models that better capture the complexity of chronic headache patients with medication overuse. This evidence concerns the gene CCR2 and headache disorder.